Genetic and rare liver diseases pose a particular challenge in hepatology. These diseases, such as Wilson's disease, alpha-1 antitrypsin deficiency or progressive familial intrahepatic cholestasis (PFIC), are often difficult to diagnose and require specialized treatment approaches. However, advances in genetic research and innovative therapy options offer new perspectives for patients. Our event brings experts together to discuss current developments, diagnostic options and future-oriented treatments - with the aim of improving the care and quality of life of those affected.